- Home
- Automated
- List of product information
- NEPHROSTERIL FOR INTRAVENOUS INFUSION [SIN06299P]
NEPHROSTERIL FOR INTRAVENOUS INFUSION [SIN06299P]
Active ingredients: NEPHROSTERIL FOR INTRAVENOUS INFUSION
Product Info
NEPHROSTERIL FOR INTRAVENOUS INFUSION
[SIN06299P]
Product information
Active Ingredient and Strength | ACETYLCYSTEINE EQV L-CYSTEINE - 0.37 G/L |
Dosage Form | INJECTION |
Manufacturer and Country | FRESENIUS KABI AUSTRIA GMBH - AUSTRIA |
Registration Number | SIN06299P |
Licence Holder | FRESENIUS KABI (SINGAPORE) PTE LTD |
Forensic Classification | GENERAL SALE LIST |
Anatomical Therapeutic Chemical (ATC) code | B05BA01 |
Indications
Balanced supply of protein elements in acute and chronic renal insufficiency as well as during peritoneal and hemodialysis treatment.
Application and Dosage
For intravenous infusion.
If not otherwise prescribed up to 0.5 g amino acids/kg BW and day ≙ 500 ml per day at 70 kg body weight in acute and chronic renal insufficiency without dialysis treatment. Up to 1 g amino acids/kg BW and day ≙ 1000 ml per day at 70 kg BW in acute and chronic renal insufficiency under hemodialysis, hemofiltration or peritoneal dialysis treatment.
Max. dosage:
up to 1.5 g amino acids/kg BW and day ≙ 1500 ml per day at 70 kg body weight.
The drop rate should not exceed 20 drops/minute.
Administer calory carriers either before or simultaneously by mouth or parenterally.
Duration of Application
In acute renal insufficiency duration of application is from some days up to maximum of two weeks.
In chronic renal insufficiency without dialysis treatment as well as in acute and chronic renal insufficiency under hemodialysis, hemofiltration, or peritoneal dialysis treatment Nephrosteril can be used until a sufficient oral supply of protein can be again given.
Contraindications
Impaired amino acid metabolism, advanced functional impairment of the liver, severe cardiac insufficiency, hyperhydration, hypokalemia, hyponatremia.
